BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7267470)

  • 21. Scleroderma in childhood.
    Singsen BH
    Pediatr Clin North Am; 1986 Oct; 33(5):1119-39. PubMed ID: 3532005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic and localized scleroderma.
    Chung L; Lin J; Furst DE; Fiorentino D
    Clin Dermatol; 2006; 24(5):374-92. PubMed ID: 16966019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The clinical picture of morphea].
    Wojas-Pelc A; Wielowieyska-Szybińska D
    Przegl Lek; 2007; 64(6):438-41. PubMed ID: 18159855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scleroderma mimics - Clinical features and management.
    Orteu CH; Ong VH; Denton CP
    Best Pract Res Clin Rheumatol; 2020 Feb; 34(1):101489. PubMed ID: 32147386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Localized and systemic scleroderma.
    Hawk A; English JC
    Semin Cutan Med Surg; 2001 Mar; 20(1):27-37. PubMed ID: 11308134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Scleroderma in children.
    Uziel Y; Miller ML; Laxer RM
    Pediatr Clin North Am; 1995 Oct; 42(5):1171-203. PubMed ID: 7567191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Localized scleroderma and systemic sclerosis: is there a connection?
    Gupta RA; Fiorentino D
    Best Pract Res Clin Rheumatol; 2007 Dec; 21(6):1025-36. PubMed ID: 18068859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognosis and management of scleroderma and scleroderma-like disorders in children.
    Black CM
    Clin Exp Rheumatol; 1994; 12 Suppl 10():S75-81. PubMed ID: 7955633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scleroderma in children and adolescents.
    Murray KJ; Laxer RM
    Rheum Dis Clin North Am; 2002 Aug; 28(3):603-24. PubMed ID: 12380372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update on management of scleroderma.
    Sule SD; Wigley FM
    Bull Rheum Dis; 2000; 49(10):1-4. PubMed ID: 11286150
    [No Abstract]   [Full Text] [Related]  

  • 31. Pediatric scleroderma.
    Emery H
    Semin Cutan Med Surg; 1998 Mar; 17(1):41-7. PubMed ID: 9512106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Systemic sclerosis--clinical course and treatment possibilities].
    Szymańska E; Maj M; Rudnicka L
    Przegl Lek; 2005; 62(12):1538-41. PubMed ID: 16786791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review.
    Ferreli C; Gasparini G; Parodi A; Cozzani E; Rongioletti F; Atzori L
    Clin Rev Allergy Immunol; 2017 Dec; 53(3):306-336. PubMed ID: 28712039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential diagnosis of scleroderma and pseudoscleroderma.
    Fabri M; Hunzelmann N
    J Dtsch Dermatol Ges; 2007 Nov; 5(11):977-84. PubMed ID: 17976138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Systemic scleroderma].
    Rommel A
    Sem Hop; 1984 Mar; 60(10):710-24. PubMed ID: 6322321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Scleroderma--clinical aspects.
    Black CM
    J Intern Med; 1993 Aug; 234(2):115-8. PubMed ID: 8340733
    [No Abstract]   [Full Text] [Related]  

  • 37. Scleroderma.
    Leininger SM
    RN; 2003 Jul; 66(7):35-40; quiz 42. PubMed ID: 12900996
    [No Abstract]   [Full Text] [Related]  

  • 38. [Progressive systemic sclerosis].
    Schramm A; Maas D
    Med Klin; 1979 Nov; 74(46):1689-99. PubMed ID: 392285
    [No Abstract]   [Full Text] [Related]  

  • 39. Other rheumatic diseases in adolescence. Dermatomyositis, scleroderma, overlap syndromes, systemic vasculitis, and panniculitis.
    Hom C; Ilowite NT
    Adolesc Med; 1998 Feb; 9(1):69-83, vi. PubMed ID: 10961253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Practical Approach to Juvenile Dermatomyositis and Juvenile Scleroderma.
    McCann LJ; Pain CE
    Indian J Pediatr; 2016 Feb; 83(2):163-71. PubMed ID: 26489640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.